BR112023021908A2 - Processos melhorados para a preparação de dimetano sulfonato, 5-[2-[(4-metilsulfonilpiperazin-1-il)metil]-7-morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2-amina) dimetano sulfonato, composto, formas cristalinas, formas cristalinas de hidrato de dimetano sulfonato, hidrato de dimetano sulfonato e processo para a preparação da forma cristalina de hidrato de dimetano sulfonato - Google Patents

Processos melhorados para a preparação de dimetano sulfonato, 5-[2-[(4-metilsulfonilpiperazin-1-il)metil]-7-morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2-amina) dimetano sulfonato, composto, formas cristalinas, formas cristalinas de hidrato de dimetano sulfonato, hidrato de dimetano sulfonato e processo para a preparação da forma cristalina de hidrato de dimetano sulfonato

Info

Publication number
BR112023021908A2
BR112023021908A2 BR112023021908A BR112023021908A BR112023021908A2 BR 112023021908 A2 BR112023021908 A2 BR 112023021908A2 BR 112023021908 A BR112023021908 A BR 112023021908A BR 112023021908 A BR112023021908 A BR 112023021908A BR 112023021908 A2 BR112023021908 A2 BR 112023021908A2
Authority
BR
Brazil
Prior art keywords
sulfonate
dimethane
hydrate
preparation
dimetane
Prior art date
Application number
BR112023021908A
Other languages
English (en)
Inventor
Amala Kompella
Rao Vagicherla Kameswara
Narmada Pesaru
Reddy Muddasani Pulla
Reddy Lanki Reddy Tirumala
Chowdary Nannapaneni Venkaiah
Original Assignee
Natco Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natco Pharma Ltd filed Critical Natco Pharma Ltd
Publication of BR112023021908A2 publication Critical patent/BR112023021908A2/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01Sulfonic acids
    • C07C309/02Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/04Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing only one sulfo group

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

processos melhorados para a preparação de dimetano sulfonato, 5-[2-[(4-metilsulfonilpiperazin-1-il)metil]-7- morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2-amina) dimetano sulfonato, composto, formas cristalinas, formas cristalinas de hidrato de dimetano sulfonato, hidrato de dimetano sulfonato e processo para a preparação da forma cristalina de hidrato de dimetano sulfonato. a presente invenção descreve um processo de segunda geração aprimorado para a síntese de nrc-1111 (i, dimetano sulfonato de 5-[2-[[4- (metilsulfonil)-1-piperazinil]metil]-7-(4-morfolinil)tieno[2,3-c] piridina-5-il]-2- pirimidinamina) e nrc-1109 (ii, dimetano sulfonato de 5-[3-metil-2-[(4- metilsulfonilpiperazin-1-il)metil]-7-morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2- amina). este processo é um processo econômico, de alto rendimento e industrialmente viável para a síntese de compostos de fórmulas i e ii com alta pureza. fórmula (i) fórmula (i): r = h para nrc-1111; e fórmula (ii): r = ch3 para nrc-1109; e nrc-1111 e nrc-1109 são potenciais agentes anticancerígenos.
BR112023021908A 2021-04-21 2022-04-15 Processos melhorados para a preparação de dimetano sulfonato, 5-[2-[(4-metilsulfonilpiperazin-1-il)metil]-7-morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2-amina) dimetano sulfonato, composto, formas cristalinas, formas cristalinas de hidrato de dimetano sulfonato, hidrato de dimetano sulfonato e processo para a preparação da forma cristalina de hidrato de dimetano sulfonato BR112023021908A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN202141018380 2021-04-21
PCT/IN2022/050363 WO2022224267A1 (en) 2021-04-21 2022-04-15 Improved process for the preparation of 7-(morpholinyl)-2-(n-piperazinyl)methylthieno[2, 3-c]pyridine derivatives

Publications (1)

Publication Number Publication Date
BR112023021908A2 true BR112023021908A2 (pt) 2023-12-19

Family

ID=83723591

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023021908A BR112023021908A2 (pt) 2021-04-21 2022-04-15 Processos melhorados para a preparação de dimetano sulfonato, 5-[2-[(4-metilsulfonilpiperazin-1-il)metil]-7-morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2-amina) dimetano sulfonato, composto, formas cristalinas, formas cristalinas de hidrato de dimetano sulfonato, hidrato de dimetano sulfonato e processo para a preparação da forma cristalina de hidrato de dimetano sulfonato

Country Status (11)

Country Link
US (1) US20240199637A1 (pt)
EP (1) EP4326276A4 (pt)
JP (1) JP2024517127A (pt)
CN (1) CN117529325A (pt)
AU (1) AU2022260846A1 (pt)
BR (1) BR112023021908A2 (pt)
CA (1) CA3216161A1 (pt)
CO (1) CO2023015302A2 (pt)
IL (1) IL307871A (pt)
MX (1) MX2023012427A (pt)
WO (1) WO2022224267A1 (pt)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2008141356A (ru) * 2006-04-26 2010-06-10 Ф. Хоффманн-Ля Рош Аг (Ch) Производные пиримидина в качестве ингибиторов фосфатидилинозитол-3-киназы (pi3k)
US8735387B2 (en) * 2008-07-15 2014-05-27 Sanofi Oxazolopyrimidines as Edg-1 receptor agonists
WO2011055770A1 (ja) * 2009-11-06 2011-05-12 武田薬品工業株式会社 縮合複素環化合物
RS53768B1 (sr) * 2010-12-16 2015-06-30 F. Hoffmann-La Roche Ag. Triciklična pi3k inhibitorna jedinjenja i postupci korišćenja
WO2013170068A2 (en) * 2012-05-09 2013-11-14 Karyopharm Therapeutics, Inc. Nuclear transport modulators and uses thereof
JP6470310B2 (ja) * 2014-04-11 2019-02-13 武田薬品工業株式会社 シクロプロパンアミン化合物およびその用途
ES2881611T3 (es) * 2014-09-12 2021-11-30 Chugai Pharmaceutical Co Ltd Producto farmacéutico que contiene inhibidor del transportador de fosfato dependiente de sodio
PT3230289T (pt) * 2014-12-11 2019-10-30 Natco Pharma Ltd Derivados de 7-(morfolinil)-2-(n-piperazinil)-metiltieno[2,3-c] piridinas como fármacos anticancro

Also Published As

Publication number Publication date
US20240199637A1 (en) 2024-06-20
EP4326276A4 (en) 2025-07-30
IL307871A (en) 2023-12-01
JP2024517127A (ja) 2024-04-19
AU2022260846A1 (en) 2023-11-16
EP4326276A1 (en) 2024-02-28
CA3216161A1 (en) 2022-10-27
CO2023015302A2 (es) 2023-11-20
CN117529325A (zh) 2024-02-06
MX2023012427A (es) 2024-02-09
WO2022224267A1 (en) 2022-10-27

Similar Documents

Publication Publication Date Title
KR101782833B1 (ko) 수지 조성물 및 그것을 사용한 패턴 형성 방법
EP1600437A4 (en) ACID GENERATORS, SULFONIC ACIDS, SULPHONYLHALOGENIDES, AND RADIATION COMPOUND SENSITIVE COMPOSITIONS
CA3084675A1 (en) Sulfonamide derivatives for protein degradation
DE60128343D1 (de) Pyrimidine verbindungen
CY1117132T1 (el) Παραγωγο θειαζολιου
AR056327A1 (es) Compuestos de nucleosidos para el tratamiento de infecciones virales
HUP0302891A2 (hu) PDE4 izoenzimek inhibitoraiként alkalmazható éterszármazékok, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
WO2003024441A1 (en) Novel use of tricyclic compound
WO2011035534A1 (zh) 二氢喋啶酮类衍生物、其制备方法及其在医药上的应用
ZA200700227B (en) Fused pyrimidones useful in the treatment and the prevention of cancer
AR036501A1 (es) Metodo para la sintesis de hexahidro-furo[2,3-b]furan-3-ol, e intermediarios
RU2002120906A (ru) Производные пиперидина и пиперазина
JP2012022212A (ja) レジスト組成物、レジストパターン形成方法、新規な化合物、および酸発生剤
CN118666686B (zh) 基于Photo-Fries重排反应的单分子树脂非化学放大型光刻胶
TW200612920A (en) Novel imidazolidine derivatives
BRPI0406500A (pt) processo farmacêutico e compostos preparados pelo mesmo
BR112023021908A2 (pt) Processos melhorados para a preparação de dimetano sulfonato, 5-[2-[(4-metilsulfonilpiperazin-1-il)metil]-7-morfolino-tieno[2,3-c]piridin-5-il]pirimidin-2-amina) dimetano sulfonato, composto, formas cristalinas, formas cristalinas de hidrato de dimetano sulfonato, hidrato de dimetano sulfonato e processo para a preparação da forma cristalina de hidrato de dimetano sulfonato
DK1644389T3 (da) Pyrinidinforbindelser med phosphonatgrupper som antivirale nukleotidanaloger
HUP0400772A2 (hu) Eljárás piperazinszármazékok mezilátjainak előállítására és ezen vegyületek
CN102629074A (zh) 光酸产生剂、其制备方法及包含光酸产生剂的抗蚀剂组合物
AR130300A1 (es) Derivados novedosos deuterados de pirimidin-2-il sulfonamida
TW200502697A (en) Polyester compound with sulfonamide structure, polymer, photoresist and patterning process
SG183620A1 (en) Photoacid generator, method for producing the same, and resist composition comprising the same
WO2005000281A3 (en) Pyrazolidinedione derivatives and their use as platelet aggregation inhibitors
TW200705121A (en) Developing liquid composition, manufacturing method thereof and method for resist pattern